NEW YORK (GenomeWeb News) — Illumina and the Mayo Clinic today said they plan to co-develop molecular diagnostics for certain undisclosed diseases, Illumina said today.
Under the agreement, Illumina will provide its VeraCode technology and its know-how on the BeadArray platform to Mayo Medical Laboratories, which have had the technology since January 2005.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.